NEUROHORMONAL ASPECTS OF COGNITIVE DISORDERS IN DISCIRCULATORY ENCEPHALOPATHY
Keywords:
circulatory encephalopathy, cognitive impairment, adrenocorticotropic hormoneAbstract
Dyscirculatory encephalopathy (DE) is a chronic progressive form of cerebrovascular pathology associated with multifocal or diffuse brain lesions and manifested by a complex of neurological and neuropsychological disorders. Cognitive impairment in DE is one of the most important and complex problems of modern neurology. Of no small importance is the neurohormonal factor in the pathogenesis of the development of CI in DE. This review article considers in detail the etiology and pathogenesis of CI in DE. Special attention is paid to the study of the role of adrenocorticotropic hormone (ACTH) as a neuropeptide in the functional activity of the brain.
References
Бородкин Ю. С. Фармакология краткосрочной памяти. -М., 1981. - 121 с.
Бородкин Ю. С., Зайцев Ю. В. Основы долговременной памяти. -М.: Медицина, 1982. -214 с.
Бородкин Ю. С., Зайцев Ю. В. Фармакология памяти //Физиология человека. -№7. -С. 963-989.
Бородкин Ю. С., Шабанов П. Д. Нейрохимические механизмы извле¬чения следов памяти. -М.: Наука, 1986. -149 с.
Кадыков А.С., Шахпаронова Н.В., Кашина Е.М. Возможности холинергической терапии больных с хроническими прогрессирующими сосудистыми заболеваниями головного мозга // Атмосфера. Нервные болезни. 2006. № 2. С.24–26
Румянцева С.А., Кравчук А.А., Рыжова Д.Д. Терапия когнитивных расстройств у больных с хронической ишемией головного мозга // РМЖ. 2007. № 5. С.379–385
Рядовая Л.А., Гуткевич Е.В., Иванова С.А., Семке В.Я. // Нейрогормональные особенности психической дезадаптации на модели невротических расстройств Современные проблемы науки и образования. – 2008. – № 5.
Alagiakrishnan K., McCracken P., Feldman H. Treating vascular risk factors and maintaining vascular health: Is this the way towards successful cognitive ageing and preventing cognitive decline? // Postgrad. Med. J. 2006. Vol. 82. P.101–105.
Burmester B., Leathem J., Merrick P. Subjective cognitive complaints and objective cognitive function in aging: a systematic review and meta-analysis of cross-sectional finding // Neuropsychology. 2016. Vol. 26 (4). P.376–393.
De Haan E.H., Nys G.M., Van Zandvoort M.J. Cognitive function following stroke and vascular cognitive impairment // Curr.Opin. Neurol. 2006. Vol. 19. P.559–564.
Diagnostic and statistical manual of mental diseases. 5th ed. (DSM-5, DSM–V). Washington, DC: London: American Psychiatric Association, 2013. 970 p.
Dolman R., Roy E.A., Dimeck P.T., Hall C.R. Age, gesture span, and dissociations among component subsystems of working memory // Brain Cogn. 2000. Vol. 43. P.164–168.
Farfel J.M., Nitrini R., Suemoto C.K. et al. Very low levels of education and cognitive reserve: A clinicopathologic study // Neurology. 2013. Vol. 81. P.650–657.
Fernández-Blázquez M.A., Avila-Villanueva M., Maestu F. et al. Specific features of subjective cognitive decline predict faster conversion to mild cognitive impairment // J. Alzheimers Dis. 2016. Vol. 52 (1). P.272–281.
Fjell A.M., Walhoyd K.B. Structural brain changes in aging: courses, causes and cognitive consequences // Rev. Neurosci. 2011. Vol. 21 (3). P.187–221.
ХР Рахматуллаев, АМ Джураев, Р Дж Халимов. Хирургическое лечение болезни Пертеса у детей. В сборнике статей "Турнеровские чтения" 54.58 Е 36. С. 304-307. 2020.
Ghaffar O., Fiati M., Feinstein A. Occupational attainment as a market of cognitive reserve in multiple sclerosis // PLoS. 2012. 7. Vol. 10. P.47206.
Grabowska A. Sex on the brain: Are gender-dependent structural and functional differences associated with behavior? // J. Neurosci. Res. 2016. Vol. 95 (1–2). P.200–212.
Jessen F., Amariglio R.E., van Boxtel M. et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer`s disease // Alzheimers Dement. 2014. Vol. 10 (6). P.844–852.
Hashimoto K. Idebenone. In: Evidence-based dementia practice / Eds.N. Qizilbash et al. // Oxford: Blackwell Sciences. 2002. Р.530–535.
Hill M.D., Mitchell J.R. White matter lesions and cognition. It’s time for randomized trials to preserve intelligence // Neurology. 2006. Vol. 66. P.470–471.
Moreno M. Cognitive improvement in mild to moderate Alzheimer dementia after treatment with the acetylcholine precursor choline alfoscerate: a multi-center, double-blind, randomized, placebo-controlled trial // Clin Ther. 2003. Vol. 25 (1). P.178–193.
Kakihana M., Yamazaki N., Nagaoka A. Effects of idebenone on the levels of acetylcholine, choline, free fatty acids, and energy metabolites in the brains of rats with cerebral ischemia // Archives of Gerontology and Geriatrics. 1989. Vol. 8 (3). P.247–256.
Mitchell A.J., Beaumont H., Ferguson D. et al. Risk of dementia and mild cognitive impairment in the older people with subjective memory complaints: meta-analysis // Acta Psychiatr. Scandinavica. 2014. Vol. 130 (6). P.439–451.
Mueller S., Wang D., Fox M.D. et al. Individual variability in functional connectivity architecture of the human brain // Neuron. 2013. Vol. 77 (3). P.586–595
Nappi G., Bono G., Merlo P. et al. Long-term idebenone treatment of vascular and degenerative brain disorders of the elderly // Arch. Gerontol. Geriat // 1992. Vol. 15. P.261–269.
ХР Рахматуллаев, АМ Джураев, Р Дж Халимов. Хирургическое лечение болезни Пертеса у детей. В сборнике статей "Турнеровские чтения" 54.58 Е 36. С. 304-307. 2020.
Parnetti L., Abate G., Bartorelli L. et al. Alpha Glyceryl-Phosphorylcholine in dementia // Drugs Aging. 1993. Vol. 3. P.159–164.
Халимов Р.Дж. Современный метод лечения болезни Легга-Кальве-Пертеса у детей. Журнал травматология ортопедия и Реабилитация. №3. 2022
Petersen R.S., Touchon J., Consensus on mild cognitive impairment: EADC — ADCS // Research and Practice in Alzheimer’s Disease. 2005. Vol. 10. P.38–46.
Prince M., Bryce R., Albanese E. et al. The global prevalence of dementia: a systematic review and meta-analysis // Alzheimers Dement. 2013. 2011. Vol. 9 (1). P.63–75.
Boymurodov G.A., Dursunov A.M Transosseous osteosynthesis in the treatment of fractures of the proximal tibia. // European Journal of Molecular & Clinical Medicine ISSN 2515-8260 Volume 7, Issue 2, 2020 1110 –Р.1110-1112
Rodríguez-Sánchez E., Mora- Simón S., Patino-Alonso M.C. et al. Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study // BMC Neurology. 2011. Vol. 11. Р.147.
Dursunov A.M., Dursunova A.A. Femur Trokanterik Kirikliklarinin Cerrahi Tedavisinde yeni Cihazin Uygulama. // 27 Ulusal Turk Ortopedi ve Travmatoloji Kongresi. 24-29 Ekim 2017 Sueno Belek Kongre Merkezi Аntalya.Turkiye.
Seshadri S. Delaying dementia: Can antihypertensives prevent Alzheimer dementia? // Neurology. 2013. Vol. 81. P.860–862.
GA Boymurodov, AM Dursunov. Tranosseous osteosynthesis in the treatment of fractures of the proximal tibia. //Journal of Critical Reviews 2020, Vol: 7 (11), 1612-1615
Thyagarajan D. Mitochondrial Disease. In: Neurological Therapeutics Principles and Practice / Ed. J.H. Noseworthy. Second ed. Abingdon: Informa Healthcare // 2006. Vol. 152 (2). P.1743–1758.
Dursunov A.M. Femur Trokanterik Kirikliklarinin Cerrahi Tedavisinde yeni Cihazin Uygulamasi. // 24 Ulusal Turk Ortopedi ve Travmatoloji Kongresi. 12-16 kasim 2014 Titanic Belek Kongre Merkezi Аntalya.Turkiye
Valcour V.G., Masaki K.H., Curb J.D. et al. The detection of dementia in the primary care setting // Arch. Intern. Med. 2000. Vol. 160. Р.2964–2968.
Van Spronsen M., Hoogenraad C. Synapse pathology in psychiatric and neurologic disease // Curr. Neurol. Neurosci. Rep. 2010. Vol. 10. P.207–214.
